NewAmsterdam Pharma Company N.V. Ordinary Shares Financial Flexibility Index
NewAmsterdam Pharma Company N.V. Ordinary Shares financial flexibility index. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Financial Flexibility Index of -0.56x as of September 2025. Free cash flow of $-32.73 Million (operating CF $-32.77 Million minus capex $42.00K) represents -1% of total liabilities ($58.36 Million). See NewAmsterdam Pharma Company N.V. Ordinar (NAMS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NewAmsterdam Pharma Company N.V. Ordinary Shares (2020–2024)
Financial flexibility index of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024. Historical Financial Flexibility Index trend for NewAmsterdam Pharma Company N.V. Ordinary Shares across 5 annual periods. Check NAMS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
NewAmsterdam Pharma Company N.V. Ordinary Shares Financial Flexibility Index by Year (2020–2024)
NewAmsterdam Pharma Company N.V. Ordinary Shares financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full cash flow conversion analysis, see NAMS cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.47x | $-157.89 Million | $-158.56 Million | $107.12 Million | ▲ +38.7% |
| 2023 | -2.41x | $-141.19 Million | $-141.22 Million | $58.70 Million | ▼ -1170.0% |
| 2022 | 0.22x | $10.89 Million | $10.66 Million | $48.43 Million | ▲ +108.7% |
| 2021 | -2.60x | $-29.49 Million | $-29.51 Million | $11.36 Million | ▼ -339.5% |
| 2020 | -0.59x | $-7.33 Million | $-7.34 Million | $12.41 Million | — |